As we have seen during the coronavirus pandemic, molecular biology had become a key element in discovering and fighting infectious diseases.
And in that respect, Stilla Technologies is on top of its field with its Digital PCR Technology system called Naica. Here is why.
Back in February when China was brutally facing the tempest caused by the coronavirus, Stilla Technologies, through an association with some of its investors and distributors, gifted China with two Naica machines.
From that moment, they became an important part of the fight against the COVID-19 pandemic as they were being used by the Chinese Center for Disease Control and Prevention.
Thanks to the innovative Digital PCR applications from Stilla Technologies, the country was able to identify the virus genome and follow its evolution through time, enabling the authorities to identify who and where pockets of infected people could be found.
With the use of the Naica system, scientists across the globe can now analyze the gene expression in less than 2 hours and 30 minutes by using a 3-color detection technique. Afterwards, using the machine’s software, they can analyze the data which measure the concentrations of targeted nucleic acids.
As we saw during the sanitary crisis, there is no better way today to identify individuals who carry the virus. It is the perfect tool to uncover infectious diseases, but it can do so much more as well. It is used in gene-mapping, for DNA fingerprints and to study genetic disorders. It is particularly helpful in detecting a cancer, its type and its treatment. By testing, regularly, the doctor can identify if the patient’s treatment is working and if the cancer is receding. If not then he will be able to modify the treatment until he gets the desired effect on the sickness.
The way the process works is that doctors analyze cell-free circulating DNA through the technology of digital PCR. Its advantages are that it is an accurate and rapid test but also highly sensitive and at a low cost; all elements that make this technology so popular today.
The COVID-19 pandemic has propelled the technology ahead of anything else in molecular biology as well as for testing for infectious diseases. The use of the Naica system, after the sanitary crisis, will certainly be higher, and it is to be predicted that the next generation (a 6-color process) will have a great future in the medical and scientific worlds.